Cassidy Bio
Tel Aviv, IL · 7 known investors
Find your way into Cassidy Bio
785 people in our graph share verified history with the Cassidy Bio team — schools, employers, funds. One of them is your warm intro.
Arnon Dinurunlockedknows Yaniv Shmueli · together at Tel Aviv University (overlapped)
×4knows the team · via Tel Aviv University
×7knows the team · via Texas Instruments
Cassidy Bio develops a genomic foundation model that accelerates CRISPR gene editing therapy design by predicting optimal guides, editors, and delivery approaches. The platform enables therapeutic teams to move from multi-year trial-and-error to weeks of computational validation, shortening development timelines for life-saving genome editing medicines.
Founders & leadership
YS
Yaniv ShmueliinCTO & Co-Founder2024–2026Yaniv Shmueli is an R&D executive with over 25 years of experience in applied AI/ML systems, including work on foundational models, recommendation systems, and data infrastructure across enterprise, e-commerce, and web platforms. He is now founder of Cassidy Bio, which develops genomic foundation models to accelerate CRISPR gene therapy design.
RK
Rom KshukinCEO
AH
Ayal HendelinCSOAyal Hendel is Chief Scientific Officer at Cassidy Bio and a former Principal Investigator in genome editing who received a 2017 ERC Grant.
Investors · 7
10DTel Aviv
Ahren Innovation CapitalCambridge, Cambridgeshire
Lool Venturesreported · 2 sourcesTel Aviv · $720K – $22M
Also in the syndicate · 4
10D VCAION LabsAstraZenecaMerck KGaA
Funding
SEC filings, press & company announcements$8M disclosed across 1 round · 2025
- $8MSeed roundNov 2025 · 4 sources
Ahren Innovation Capital (lead), 10D VC, AION Labs, AstraZeneca, lool Ventures, Merck KGaA
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Cassidy Bio do?
- Cassidy Bio develops a genomic foundation model that accelerates CRISPR gene editing therapy design by predicting optimal guides, editors, and delivery approaches. The platform enables therapeutic teams to move from multi-year trial-and-error to weeks of computational validation, shortening development timelines for life-saving genome editing medicines.
- Who founded Cassidy Bio?
- Cassidy Bio was founded by Yaniv Shmueli.
- Who are Cassidy Bio's investors?
- Cassidy Bio's investors include 10D, Ahren Innovation Capital, Lool Ventures.
- How much funding has Cassidy Bio raised?
- Cassidy Bio has disclosed $8M raised across 1 round.
- Where is Cassidy Bio headquartered?
- Cassidy Bio is headquartered in Tel Aviv, IL.